Sustainability
 

Sustainability is ingrained in the core of our business model. Our foremost commitment is to provide treatments to patients with unmet medical needs, thereby enhancing the quality of life for them and their families. However, this approach necessitates operating sustainably. For us, sustainability encompasses empowering our employees, fostering a positive work environment at Immedica, cultivating sustainable partnerships, and establishing a socially and environmentally responsible business that adheres to legal regulations. Immedica’s Sustainability strategy is closely aligned with the United Nations Sustainable Development Goals (SDGs). We have identified nine SDGs where we believe Immedica can make the most significant impact:

Commitment to make a difference to patients’ lives

• We improve the quality of life for patients by launching and making rare disease and niche specialty drugs avaliable to patients with high unmet medical needs.
• We prevent disease and lower the need of care by supporting in diagnosis practices, meaning patients are treated in time with less side effects.
• We focus on patient safety and quality by collecting, evaluating and minimizing errors and adverse effects associated with our drugs.

Sustainable organization and operations

• We reduce our environmental footprint and work with our suppliers and partners towards a sustainable value chain.
• We make sure that employees have a safe and sustainable working environment and help them develop.
• We operate with high compliance practice and have zero tolerance for bribery, corruption or forced labor.
• By implementing ESG due diligence in our procurement we contribute to impacting our partners’ ESG work.

Immedica uses the EcoVadis sustainability reporting platform to monitor and drive our own performance and progress and that of our supplier partners across the four themes of Environment, Labour and Human Rights, Ethics and Sustainable Procurement. 

In 2023 Immedica achieved a silver rating and one of the 25% top tier companies.